Trends in prevalence, mortality, and disability-adjusted life-years relating to Chronic Obstructive Pulmonary Disease in Europe: 2001-2019

File Description SizeFormat 
COPD Final.docxFile embargoed until 01 January 10000217.4 kBMicrosoft Word    Request a copy
Title: Trends in prevalence, mortality, and disability-adjusted life-years relating to Chronic Obstructive Pulmonary Disease in Europe: 2001-2019
Authors: Marshall, D
Al Omari, O
Goodall, R
Shalhoub, J
Adcock, I
Chung, K
Salciccioli, J
Item Type: Journal Article
Abstract: Introduction: Chronic Obstructive Pulmonary Disease (COPD) is associated with significant mortality and well-defined etiological factors. Previous reports indicate that mortality from COPD is falling worldwide. This study aims to assess the burden of COPD using prevalence, mortality, and disability-adjusted life years (DALYs) between 2001-2019 in 28 European countries (the European Union and the United Kingdom). Methods: We extracted COPD data from the Global Burden of Disease database based on the International Classification of Diseases versions 10 (J41,42,43,44, and 47). Age-standardised prevalence rates (ASPRs), age-standardised mortality rates (ASMRs), and DALYs were analysed for European countries by sex for each year (2001-2019) and reported per 100,000 population. We used Joinpoint regression analysis to quantify changing trends in the burden of COPD. Results: In 2019, the median ASPR across Europe was 3230/100,000 for males and 2202/100,000 for females. Between 2001 and 2019, the median percentage change in ASPR was -9.7% for males and 4.3% for females. 23/28 countries demonstrated a decrease in ASPRs in males, and 11/28 demonstrated a decrease in females. The median percentage change in ASMR between 2001-2019 was -27.5% for males and -10.4% for females. 25/28 and 19/28 countries demonstrated a decrease in ASMR in males and females, respectively. Conclusion: In the EU between 2001 and 2019 COPD prevalence has overall increased in females but continues to decrease in males and in some countries, female prevalence now exceeds that of males. COPD mortality in the EU has decreased overall between 2001 and 2019; however, this decrease is not universal, particularly in females, and therefore remains a substantial source of amenable mortality. Funding: DCM is supported by an NIHR Academic Clinical Fellowship acknowledges support from the National Institute for Health Research (NIHR) Imperial Biomedical Research Centre. KFC is a Senior Investigator of the National Institute for Health Research (NIHR), UK.
Date of Acceptance: 8-Jul-2022
URI: http://hdl.handle.net/10044/1/98357
ISSN: 1471-2466
Publisher: BioMed Central
Journal / Book Title: BMC Pulmonary Medicine
Copyright Statement: This paper is embargoed until publication. Once published it will be available fully open access.
Keywords: Respiratory System
1102 Cardiorespiratory Medicine and Haematology
Publication Status: Accepted
Embargo Date: This item is embargoed until publication
Appears in Collections:Department of Surgery and Cancer
National Heart and Lung Institute